Explore the words cloud of the PMSMatTrain project. It provides you a very rough idea of what is the project "PMSMatTrain" about.
The following table provides information about the project.
NATIONAL UNIVERSITY OF IRELAND GALWAY
|Coordinator Country||Ireland [IE]|
|Total cost||3˙962˙143 €|
|EC max contribution||3˙962˙143 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2019-05-01 to 2023-04-30|
Take a look of project's partnership.
|1||NATIONAL UNIVERSITY OF IRELAND GALWAY||IE (Galway)||coordinator||1˙373˙421.00|
|2||UNIVERSITEIT ANTWERPEN||BE (ANTWERPEN)||participant||512˙640.00|
|3||WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER||DE (MUENSTER)||participant||505˙576.00|
|4||NEOS SURGERY SL||ES (DONOSTIA SAN SEBASTIAN)||participant||501˙809.00|
|5||SYDDANSK UNIVERSITET||DK (ODENSE M)||participant||297˙522.00|
|6||UNIVERSITE GRENOBLE ALPES||FR (GRENOBLE)||participant||274˙802.00|
|7||UNIVERSITA DEGLI STUDI GABRIELE D'ANNUNZIO DI CHIETI-PESCARA||IT (CHIETI)||participant||261˙499.00|
|8||CONTIPRO AS||CZ (DOLNI DOBROUC)||participant||234˙871.00|
|9||UNIVERSITE GRENOBLE ALPES||FR (SAINT MARTIN D'HERES)||participant||0.00|
PMSMatTrain is focusing on gaining a comprehensive understanding of the progressive (late degenerative phase) of multiple sclerosis (PMS) from basics to translation, fully supported by 8 beneficiaries (6 research institutions, 2 SMEs). Recruited ESRs will receive compulsory discipline-specific, generic and complementary transferable skills training. PMSMatTrain’s Joint Research Education and Training programme (JRTP) will provide early stage researchers with high quality research and transferable skills training in intellectual property, leadership skills, innovation, regulatory affairs, entrepreneurship, gender policy, and medical device evaluation, which will ensure that they are immediately employable in industry. The consortium will develop a multi-modal hyaluronan-based medical device designed to release small molecular weight anti-inflammatory molecules (APRIL and sPIF) followed by remyelination and neuroprotective drugs (ibudilast and miconazole). PMSMatTrain will for the first time utilise these functionalised multi-modal biomimetic hyaluronan scaffolds as a tool to investigate cross-talk between signals arising due to chronic neuroinflammation and those leading to demyelination and axonal loss, while identifying molecular mechanisms that facilitate remyelination and neuroprotection in PMS. This approach could yield the first cortex-proximal and directed biomaterials-based disease-modifying therapy for PMS. These scaffolds will be tested in state of the art MS patient induced stem cell-derived oligodendrocyte cultures and organotypic cultures to investigate MS pathophysiology. In vivo responses will be characterised using field-leading MRI and mass spectrophotometry protocols. PMSMatTrain will also generate a clinically-relevant in silico model of drug elusion and dispersal within the CNS. Our industry partners will develop the end-device by providing standardised manufacturing protocols for scaled-up production and commercialisation of the cGMP product.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PMSMATTRAIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PMSMATTRAIN" are provided by the European Opendata Portal: CORDIS opendata.